Pirtobrutinib in covalent BTK-inhibitor pre- treated relapsed/refractory (R/R) Mantle Cell Lymphoma

被引：0
|
作者：
Fileni, Caroline [1 ]
Sarkozy, Clementine [2 ]
机构：
[1] Hop Archet 1, Serv Hematol, Nice, France
[2] Inst Curie St Cloud, Serv Hematol, St Cloud, France
来源：
BULLETIN DU CANCER | 2023年 / 110卷 / 10期
关键词：
Mantle cell lymphoma; Relapse; Refractory; Covalent BTK-inhibitor; Non covalent BTK-inhibitor;
D O I：
10.1016/j.bulcan.2023.07.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：988 / 990
页数：3
相关论文
共 50 条
  • [1] Pirtobrutinib efficacy in covalent BTK-inhibitor pre-treated relapsed/refractory mantle cell lymphoma: Extended follow-up from BRUIN
    Lewis, David John
    Wang, Michael L.
    Shah, Nirav N.
    Jurczak, Wojciech
    Zinzani, Pier Luigi
    Eyre, Toby A.
    Cheah, Chan Y.
    Ujjani, Chaitra S.
    Koh, Youngil
    Izutzu, Koji
    Gerson, James N.
    Flinn, Ian
    Tessoulin, Benoit
    Alencar, Alvaro J.
    Ma, Shuo
    Lech-Maranda, Ewa
    Rhodes, Joanna
    Patel, Krish
    Woyach, Jennifer
    Lamanna, Nicole
    Wang, Yucai
    Tam, Constantine
    Seymour, John F.
    Munir, Talha
    Nagai, Hirokazu
    Hernandez-Ilizaliturri, Francisco
    Kumar, Anita
    Zelenetz, Andrew
    Jain, Preteesh
    Nair, Binoj
    Tsai, Donald E.
    Balbas, Minna
    Walgren, Richard A.
    Abada, Paolo
    Wang, Chunxiao
    Zhao, Junjie
    Mato, Anthony R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 108 - 109
  • [2] Pirtobrutinib: A novel non-covalent BTK inhibitor for the treatment of adults with relapsed/refractory mantle cell lymphoma
    Davis, Dominique D.
    Ohana, Zahava
    Pham, Huy M.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (01) : 182 - 188
  • [3] Efficacy of Pirtobrutinib in Covalent BTK-Inhibitor Pre-Treated Relapsed / Refractory Mantle Cell Lymphoma: Additional Patients and Extended Follow-up from the Phase 1/2 BRUIN Study
    Wang, Michael L.
    Shah, Nirav N.
    Jurczak, Wojciech
    Zinzani, Pier Luigi
    Eyre, Toby A.
    Cheah, Chan Y.
    Ujjani, Chaitra S.
    Koh, Youngil
    Izutsu, Koji
    Gerson, James N.
    Flinn, Ian W.
    Tessoulin, Benoit
    Alencar, Alvaro J.
    Ma, Shuo
    Lech-Maranda, Ewa
    Rhodes, Joanna M.
    Patel, Krish
    Woyach, Jennifer A.
    Lamanna, Nicole
    Wang, Yucai
    Tam, Constantine S.
    Seymour, John F.
    Munir, Talha
    Nagai, Hirokazu
    Hernandez-Ilizaliturri, Francisco
    Kumar, Anita
    Zelenetz, Andrew D.
    Jain, Preetesh
    Nair, Binoj
    Tsai, Donald E.
    Balbas, Minna
    Walgren, Richard A.
    Abada, Paolo B.
    Wang, Chunxiao
    Zhao, Junjie
    Mato, Anthony R.
    BLOOD, 2022, 140 : 9368 - 9372
  • [4] Pirtobrutinib efficacy in covalent BTK-inhibitor pre-treated relapsed/refractory CLL/SLL: Additional patients and extended follow-up from BRUIN
    Munir, Talha
    Mato, Anthony R.
    Woyach, Jennifer A.
    Brown, Jennifer R.
    Ghia, Paolo
    Patel, Krish
    Eyre, Toby A.
    Lech-Maranda, Ewa
    Lamanna, Nicole
    Tam, Constantine S.
    Seymour, John F.
    Shah, Nirav N.
    Coombs, Catherine C.
    Ujjani, Chaitra S.
    Patel, Manish R.
    Fakhri, Bita
    Cheah, Chan Y.
    Alencar, Alvaro J.
    Cohen, Jonathon B.
    Gerson, James N.
    Flinn, Ian W.
    Ma, Shuo
    Jagadeesh, Deepa
    Rhodes, Joanna M.
    Hernandez-Ilizaliturri, Francisco
    Zinzani, Pier Luigi
    Balbas, Minna
    Nair, Binoj
    Abada, Paolo
    Wang, Chunxiao
    Wang, Denise
    Tsai, Donald E.
    Wierda, William G.
    Jurczak, Wojciech
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 110 - 111
  • [5] Efficacy of R-BAC in relapsed, refractory mantle cell lymphoma post BTK inhibitor therapy
    McCulloch, Rory
    Visco, Carlo
    Eyre, Toby A.
    Frewin, Rebecca
    Phillips, Neil
    Tucker, David L.
    Quaglia, Francesca M.
    McMillan, Annabel
    Lambert, Jonathan
    Crosbie, Nicola
    Rule, Simon
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (04) : 684 - 688
  • [6] Efficacy of R-BAC immunochemotherapy in patients with relapsed, refractory mantle cell lymphoma post BTK inhibitor therapy
    McCulloch, R.
    Frewin, R.
    Tucker, D.
    Kerr, J. P.
    Phillips, N.
    Gandla, J.
    Crosbie, N.
    Lewis, D.
    Rule, S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 88 - 88
  • [7] Pirtobrutinib: First Non-covalent Tyrosine Kinase Inhibitor for Treating Relapsed or Refractory Mantle Cell Lymphoma in Adults
    De, Surya K.
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (30) : 4757 - 4762
  • [8] Pirtobrutinib, a Non-Covalent (reversible) BTK Inhibitor, in Mantle Cell Lymphoma Patients Previously Treated with a Covalent BTK Inhibitor: Results from a China Phase 2 Study
    Song, Yuqin
    Yi, Shuhua
    Yang, Haiyan
    Feng, Ru
    Huang, Huiqiang
    Zhang, Qingyuan
    Liu, Yanyan
    Guo, Ye
    Zhang, Huilai
    Zhang, Liling
    Qian, Yijiao
    Zhu, JianKun
    Zhu, Jun
    BLOOD, 2023, 142
  • [9] Evaluating pirtobrutinib for the treatment of relapsed or refractory mantle cell lymphoma
    Wang, Jacqueline F.
    Wang, Yucai
    EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (10) : 651 - 659
  • [10] Zanubrutinib: a new BTK inhibitor for treatment of relapsed/refractory mantle cell lymphoma
    Weaver, A. N.
    Jimeno, A.
    DRUGS OF TODAY, 2020, 56 (08) : 531 - 539
12345